Cytotoxic Engineered Induced Neural Stem Cells as an Intravenous Therapy for Primary Non–Small Cell Lung Cancer and Triple-Negative Breast Cancer
Converting human fibroblasts into personalized induced neural stem cells (hiNSC) that
actively seek out tumors and deliver cytotoxic agents is a promising approach for treating …
actively seek out tumors and deliver cytotoxic agents is a promising approach for treating …
Cytotoxic Engineered Induced Neural Stem Cells as an Intravenous Therapy for Primary Non-Small Cell Lung Cancer and Triple-Negative Breast Cancer
AR Mercer-Smith, W Jiang, JR Bago… - Molecular cancer …, 2021 - pubmed.ncbi.nlm.nih.gov
Converting human fibroblasts into personalized induced neural stem cells (hiNSC) that
actively seek out tumors and deliver cytotoxic agents is a promising approach for treating …
actively seek out tumors and deliver cytotoxic agents is a promising approach for treating …
[HTML][HTML] Cytotoxic Engineered Induced Neural Stem Cells as an Intravenous Therapy for Primary Non-Small Cell Lung Cancer and Triple-Negative Breast Cancer
AR Mercer-Smith, W Jiang, JR Bago… - Molecular cancer …, 2021 - ncbi.nlm.nih.gov
Converting human fibroblasts into personalized induced neural stem cells (hiNSCs) that
actively seek out tumors and deliver cytotoxic agents is a promising approach for treating …
actively seek out tumors and deliver cytotoxic agents is a promising approach for treating …
Cytotoxic Engineered Induced Neural Stem Cells as an Intravenous Therapy for Primary Non-Small Cell Lung Cancer and Triple-Negative Breast Cancer.
AR Mercer-Smith, W Jiang, JR Bago… - Molecular Cancer …, 2021 - europepmc.org
Converting human fibroblasts into personalized induced neural stem cells (hiNSCs) that
actively seek out tumors and deliver cytotoxic agents is a promising approach for treating …
actively seek out tumors and deliver cytotoxic agents is a promising approach for treating …